Evidence map›Paper›PMID 31151839›Full record

ReviewJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2019

Pathophysiology of Lacunar Stroke: History's Mysteries and Modern Interpretations.

Robert W Regenhardt, Alvin S Das, Ryo Ohtomo, Eng H Lo, Cenk Ayata, Mahmut Edip Gurol

Open access · greenAbstract readHistorical ArticleReview
In one paragraph

Review in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Promoter hypomethylation ofFrontiers in genetics · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Robert W RegenhardtDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Alvin S DasDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Ryo OhtomoDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Eng H LoDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Cenk AyataDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Mahmut Edip GurolDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: edip@mail.harvard.edu.
Harvard University · USBrigham and Women's Hospital · US

Funding

Targeting ROCK for Neurogliovascular Plasticity & Remodeling After StrokeP01NS055104 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI LO, ENG H. · 2007 to 2018
$13.3M
Neuroscience Resident Research ProgramR25NS065743 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CASH, SYDNEY S, WILLIAMS, ZIV · 2009 to 2023
$11.8M
Role of Tau Conformations in Vascular Contribution to Cognitive Impairment and DementiaR01AG055559 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LO, ENG H., SHEHADAH, AMJAD · 2017 to 2021
$3.4M
Pericyte Mechanisms in Traumatic Brain InjuryR01NS103786 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI LO, ENG H. · 2018 to 2022
$1.9M
Thrombolysis Profiles in tPA ResponseR01NS093415 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI LO, ENG H., NING, MINGMING · 2015 to 2019
$1.9M
Inflammatory Mechanisms of Brain - Lymphatic Signaling in StrokeR01NS099620 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HAYAKAWA, KAZUHIDE, LO, ENG H. · 2016 to 2020
$1.9M
Non-invasive vagus nerve stimulation targeting cortical spreading depression in migrane prophylaxisR01NS102969 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI AYATA, CENK · 2017 to 2021
$1.9M
Molecular Neuroimaging of Disease Mechanisms in Cerebral Amyloid AngiopathyK23NS083711 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GUROL, MAHMUT EDIP · 2014 to 2018
$988k
NIA NIH HHS R01 AG055559NINDS NIH HHS K23 NS083711NINDS NIH HHS P01 NS055104NINDS NIH HHS R01 NS093415NINDS NIH HHS R01 NS099620NINDS NIH HHS R01 NS102969NINDS NIH HHS R01 NS103786NINDS NIH HHS R25 NS065743
6 · The paper itself

Abstract

Since the term "lacune" was adopted in the 1800s to describe infarctions from cerebral small vessels, their underlying pathophysiological basis remained obscure until the 1960s when Charles Miller Fisher performed several autopsy studies of stroke patients. He observed that the vessels displayed segmental arteriolar disorganization that was associated with vessel enlargement, hemorrhage, and fibrinoid deposition. He coined the term "lipohyalinosis" to describe the microvascular mechanism that engenders small subcortical infarcts in the absence of a compelling embolic source. Since Fisher's early descriptions of lipohyalinosis and lacunar stroke (LS), there have been many advancements in the understanding of this disease process. Herein, we review lipohyalinosis as it relates to modern concepts of cerebral small vessel disease (cSVD). We discuss clinical classifications of LS as well as radiographic definitions based on modern neuroimaging techniques. We provide a broad and comprehensive overview of LS pathophysiology both at the vessel and parenchymal levels. We also comment on the role of biomarkers, the possibility of systemic disease processes, and advancements in the genetics of cSVD. Lastly, we assess preclinical models that can aid in studying LS disease pathogenesis. Enhanced understanding of this highly prevalent disease will allow for the identification of novel therapeutic targets capable of mitigating disease sequelae.

Indexed as

AnimalsBiomarkersBiopsyBrainCerebral ArteriesCerebrovascular CirculationGenetic Predisposition to DiseaseHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHumansNeuroimagingPhenotypePredictive Value of TestsPrognosisRisk FactorsBiomarkerscerebral small vessel diseasegeneticslacunar strokeStroke

Identifiers

PMID31151839
PMCPMC7416422
OpenAlexW2947334374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.